Search Results

-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases . World J Gastroenterol 2006 ; 12 : 3716 – 3721 . 10.3748/wjg.v12.i23.3716 16773688 49. Vanpouille-Box C , Alard A , Aryankalayil MJ , DNA exonuclease Trex1

; 24 : 1560 – 1567 . 15. Abdalla EK Vauthey JN Ellis LM . Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases . Ann Surg 2004 ; 239 : 818 – 825

with grade ≥2 liver injury should undergo a contrast-enhanced CT or MRI of the liver to exclude liver metastases and/or pancreaticobiliary disease. If the imaging is negative or demonstrates stable disease, hepatology referral is recommended for further

metastases are commonly distributed in both lobes, often precluding standard hepatectomies for complete resection. Radiofrequency ablation (RFA), hepatic artery embolization, and liver transplantation are other alternative options for treating liver

retrospective analysis of 106 patients with squamous cell carcinoma reported that resection or ablation of liver metastases can result in long-term survival and that patients with anal cancer had better outcomes than those with nonanal squamous cell carcinoma

performed with CT or MRI. Lung metastases occur in approximately 4%–9% of patients with colon and rectal cancer, 37 – 39 and studies have shown that 20%–34% of patients with CRC present with synchronous liver metastases. 40 , 41 The consensus of the panel

inhibitor. 60 The confirmed ORR was 44% (95% CI, 35.1%–53.2%), including 12% complete responses. Similar response rates were seen in subgroups of patients with liver metastases and in those with no response to prior ICI therapy. The median DoR was 7

the prognosis of colorectal cancer . Ann Surg Oncol 2010 ; 17 : 416 – 424 . 70. Nash GM Gimbel M Shia J . KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases . Ann Surg Oncol

for a cure . Onkologie 2006 ; 29 : 5 – 6 . 73. Ajani JA Carrasco CH Jackson DE Wallace S . Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal . Am J Med 1989

.5%; P =.63). Similarly, results of a single-center, nonrandomized phase II trial of patients with potentially resectable liver metastases showed no increase in bleeding or wound complications when the bevacizumab component of CAPEOX plus bevacizumab